openPR Logo
Press release

Why is the APAC Generic Drugs Market Growing at a 7.2% CAGR Until 2034?

06-02-2025 04:48 PM CET | Health & Medicine

Press release from: Expert Market Research

Why is the APAC Generic Drugs Market Growing at a 7.2% CAGR Until

The Asia Pacific Generic Drugs Market was valued at USD 48.70 billion in 2024 and is expected to more than double, reaching USD 97.61 billion by 2034. With a projected CAGR of 7.20% during this period, this market is increasingly recognized as a critical segment of the broader Healthcare and Pharmaceuticals industry. The growth is driven by rising healthcare costs, governmental initiatives, and increased acceptance of generic medications across developing and developed economies within the region.

Current Market Trends in the Asia Pacific Generic Drugs Market

Several market trends are shaping the Asia Pacific generic drugs industry in 2025:

Government Policy Support: Governments in countries like India, China, and Japan have introduced initiatives to boost the production and use of generic drugs. These include price controls, expedited drug approvals, and public procurement programs.

Patent Expiries of Branded Drugs: As patents for blockbuster drugs expire, generic manufacturers are increasingly stepping in to fill the supply gap with cost-effective alternatives, increasing market competition.

Rise of Biosimilars: Generic drug makers are gradually moving into the biosimilar space, particularly in oncology and rheumatology segments, which is expanding the market scope.

Digital Health and Online Pharmacies: The rise of e-commerce in healthcare, including online pharmacies, is reshaping how generic drugs are distributed, making them more accessible in both urban and rural regions.

Read Full Report with Table of Contents - https://bitl.to/4dNH

Key Market Drivers

The expansion of the Asia Pacific Generic Drugs Market is powered by multiple factors:

Affordable Healthcare Push: The need to reduce public healthcare spending has made generics a strategic solution for governments.

Aging Population: As life expectancy increases, so does the demand for chronic disease management - particularly in cardiovascular and rheumatology therapy areas - where generics play a central role.

Increased Awareness and Trust: Greater public confidence in the efficacy of generics is reducing hesitancy, particularly in traditionally brand-loyal markets like Japan.

Strong Manufacturing Base: Countries like India and China have emerged as major production hubs due to their cost-effective manufacturing and regulatory expertise.
Case Studies & Industry News

India's Jan Aushadhi Scheme is a standout example of a successful government initiative. The program provides generic medicines at significantly lower prices through dedicated retail outlets. As of 2025, over 10,000 stores are operational under this scheme.

In China, the Volume-Based Procurement (VBP) policy has led to dramatic reductions in drug prices. Reports from 2024 show that drug prices dropped by up to 90% in some provinces, increasing accessibility for patients and reducing state expenditure.

Major Players in the Market

Key pharmaceutical companies influencing the Asia Pacific Generic Drugs Market include:

Teva Pharmaceutical Industries Ltd
Viatris Inc.
Sun Pharmaceutical Industries Ltd
Lupin
AstraZeneca
Baxter
Takeda Pharmaceutical Company Limited
GSK plc
Bausch + Lomb
Novartis AG
Sanofi
Pfizer Inc.
Fresenius SE & Co. KGaA
Aurobindo Pharma

These companies are investing in R&D, forming strategic alliances, and expanding their regional footprints to remain competitive.

Get a Free Sample Report with Table of Contents - https://bitl.to/4dNJ

Market Segmentation

The market analysis reveals a diverse segmentation structure:

By Therapy Area

Cardiovascular
Dermatology
Respiratory
Oncology
Rheumatology
Others

By Route of Administration

Oral
Injectables
Dermal/Topical
Inhalers
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

By Region

India
China
Japan
Others

Each segment contributes uniquely to the market size and market share, reflecting variations in healthcare needs and infrastructure.

Future Growth Potential

The outlook for the Asia Pacific Generic Drugs Market remains robust. With technological advancements, regulatory streamlining, and rising healthcare literacy, generic drugs are expected to become the cornerstone of pharmaceutical care in the region.

Moreover, the increasing demand for biosimilars and the incorporation of AI in supply chain and drug development are likely to open new avenues for market expansion.

Read More Latest Reports:

Asia Pacific Viral Vector Manufacturing Market - https://bitl.to/4dNN

Asia Pacific Women's Digital Health Market - https://bitl.to/4dNO

Europe Generic Drugs Market - https://bitl.to/4dNP

Media Contact

Company Name: Claight Corporation
Contact Person: Lalit Sen, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Why is the APAC Generic Drugs Market Growing at a 7.2% CAGR Until 2034? here

News-ID: 4047371 • Views:

More Releases from Expert Market Research

Methyl Salicylate Market Size, Trends & Forecast 2025-2034
Methyl Salicylate Market Size, Trends & Forecast 2025-2034
The methyl salicylate market is witnessing steady growth, primarily driven by its increasing use in pharmaceuticals, cosmetics, and the food and beverages industry. Methyl salicylate, commonly known as wintergreen oil, finds extensive applications as a flavoring agent and a topical analgesic. With the rising demand for pain relief ointments, sports creams, and aromatic personal care products, this market continues to gain momentum globally. Moreover, its role in the synthesis of
Cocoa Butter Price Chart, Global Prices, Demand Outlook & Historical Data 2024
Cocoa Butter Price Chart, Global Prices, Demand Outlook & Historical Data 2024
Cocoa Butter Prices Surge in 2024, With Elevated Levels Likely to Persist in 2025 Cocoa butter prices in Northwest Europe soared in the final quarter of 2024, driven by global supply shortages and strong demand from the chocolate and confectionery sectors. In October 2024, the cocoa butter price surged to USD 12,530/MT, marking a 115% increase from USD 5,820/MT in October 2023. November recorded an even steeper jump of 127%, with
Enterprise Data Management Market Size, Share and Report | 2034
Enterprise Data Management Market Size, Share and Report | 2034
Enterprise Data Management Market Outlook According to the report by Expert Market Research (EMR), the global enterprise data management market attained a value of more than USD 93.01 billion in 2024. Fueled by the increasing reliance on data-driven decision-making and the need for regulatory compliance, the market is projected to grow at a CAGR of 12.80% during the forecast period of 2025-2034 to reach a value of more than USD 310.18
Fish and Seafood Market: Trends, Growth Drivers & Forecast 2025-2034
Fish and Seafood Market: Trends, Growth Drivers & Forecast 2025-2034
The global fish and seafood market has become one of the most dynamic and essential segments of the food industry, driven by rising demand for high-protein diets, growing health awareness, and shifting consumption patterns across the globe. As seafood continues to play a critical role in global nutrition and food security, the industry is experiencing structural changes, technological innovation, and expanded global trade. Get a Free Sample Report with Table

All 5 Releases


More Releases for Generic

Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth? The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall. Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs. The global generic drugs market is driven by the rise of
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems. At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of